- Home
- BMRA vs BGLC Comparison
BMRA vs BGLC Comparison
Compare BMRA & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- BGLC
- Stock Information
- Founded
- BMRA 1971
- BGLC 2017
- Country
- BMRA United States
- BGLC Malaysia
- Employees
- BMRA N/A
- BGLC N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BGLC Medical Specialities
- Sector
- BMRA Health Care
- BGLC Health Care
- Exchange
- BMRA Nasdaq
- BGLC Nasdaq
- Market Cap
- BMRA 7.4M
- BGLC 7.6M
- IPO Year
- BMRA N/A
- BGLC N/A
- Fundamental
- Price
- BMRA $0.33
- BGLC $0.37
- Analyst Decision
- BMRA
- BGLC
- Analyst Count
- BMRA 0
- BGLC 0
- Target Price
- BMRA N/A
- BGLC N/A
- AVG Volume (30 Days)
- BMRA 68.2K
- BGLC 117.9K
- Earning Date
- BMRA 10-15-2024
- BGLC 11-20-2024
- Dividend Yield
- BMRA N/A
- BGLC N/A
- EPS Growth
- BMRA N/A
- BGLC N/A
- EPS
- BMRA N/A
- BGLC N/A
- Revenue
- BMRA $5,509,000.00
- BGLC $9,183,168.00
- Revenue This Year
- BMRA N/A
- BGLC N/A
- Revenue Next Year
- BMRA N/A
- BGLC N/A
- P/E Ratio
- BMRA N/A
- BGLC N/A
- Revenue Growth
- BMRA 1.74
- BGLC N/A
- 52 Week Low
- BMRA $0.24
- BGLC $0.31
- 52 Week High
- BMRA $2.13
- BGLC $3.39
- Technical
- Relative Strength Index (RSI)
- BMRA 47.85
- BGLC 32.80
- Support Level
- BMRA $0.28
- BGLC $0.38
- Resistance Level
- BMRA $0.35
- BGLC $0.49
- Average True Range (ATR)
- BMRA 0.04
- BGLC 0.02
- MACD
- BMRA 0.00
- BGLC -0.01
- Stochastic Oscillator
- BMRA 41.67
- BGLC 5.94
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.